what is cresco labs stock

How much is Cresco Labs stock worth?

Cresco Labs is currently trading for just over $10 a share on the OTC market. This may not seem like much, but the company has seen major stock growth over the past few months. It was below $5 for much of 2020. It’s currently trading for over $13 a share on the Canadian Exchange as well.

What is Cresco Labs?

Cresco Labs was founded in 2013 and it’s currently headquartered in Chicago, Illinois. The business, much like other pot stocks, has taken advantage of the ever-growing list of states to legalize marijuana.

Is Cresco a publicly traded company?

On October 9, 2018, Cresco announced its intention to go public on the Canadian Securities Exchange (CSE) via a reverse takeover with Randsburg International Gold Corp. At the time of the announcement, Cresco was licensed to operate in Pennsylvania, Ohio, Arizona, Nevada, and California as well as Illinois.

What happened to Cresco Labs'stock in 2021?

Last year wasn't a good one for Cresco Labs ( CRLBF 2.67% ), even though it started off on the right foot. After its shares surged 71% within the first six weeks, the multi-state operator's (MSO) stock reversed course and ended 2021 off some 32% from where it began.

Is Cresco Labs a Buy Sell or Hold?

Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

How high will Cresco Labs stock go?

Stock Price Forecast The 17 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 11.95, with a high estimate of 24.19 and a low estimate of 3.90. The median estimate represents a +295.80% increase from the last price of 3.02.

Is Cresco Labs a US stock?

CRLBF Stock Price | Cresco Labs Inc. Stock Quote (U.S.: OTC) | MarketWatch.

Can I invest in Cresco Labs?

Cresco stock can be purchased by contacting a registered stock broker or through an online stock brokerage service for self-directed investors.

Should I invest in Cresco?

Valuation metrics show that Cresco Labs Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of CRLBF, demonstrate its potential to outperform the market.

Should I sell my Cresco Labs stock?

Cresco Labs Inc. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

What Company owns Cresco?

Cresco Labs, Inc.Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use....Cresco Labs.TypePublicFounded2013FounderCharlie Bachtell Joe CaltabianoHeadquartersChicago, IL7 more rows

Is Cresco Labs good quality?

Cresco Labs brands are an excellent source for cannabis products that are high in THC and are of good quality. They offer various products, and customers can trust they get THC without heavy metals or hazardous chemicals. Additionally, this company has the potential to be a wise investment.

How do I invest in Cresco?

Cresco Labs does not offer a direct purchasing option. You'll need to purchase through a registered stockbroker. You can also purchase stock through an online stock brokerage service if you're a self-directed investor. You choose what and when to buy and sell without the help of a stockbroker service.

Is Cresco Labs making money?

The Chicago-based cannabis company's revenue increased by 20% to $214 million. First-quarter adjusted Ebitda rose 45% to $51 million. Cresco Labs did not provide an earnings per share figure. Analysts expected Cresco Labs to break even in the first quarter on revenue of $211.4 million, according to a FactSet Survey.

Is Cresco Labs OTC stock?

CRLBF | Cresco Labs Inc. Stock Overview (U.S.: OTC) | Barron's.

What is US OTC stock?

Over-the-counter (OTC) securities are securities that are not listed on a major exchange in the United States and are instead traded via a broker-dealer network, usually because many are smaller companies and do not meet the requirements to be listed on a formal exchange.

Should I buy or sell Cresco Labs stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are current...

What is Cresco Labs' stock price forecast for 2022?

7 brokers have issued 1-year price objectives for Cresco Labs' stock. Their forecasts range from $5.00 to $36.00. On average, they predict Cresco L...

How has Cresco Labs' stock performed in 2022?

Cresco Labs' stock was trading at $6.67 on January 1st, 2022. Since then, CRLBF stock has decreased by 48.3% and is now trading at $3.45. View the...

Are investors shorting Cresco Labs?

Cresco Labs saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 867,900 shares, a drop of 35.0% fro...

When is Cresco Labs' next earnings date?

Cresco Labs is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Cresco...

Who are Cresco Labs' key executives?

Cresco Labs' management team includes the following people: Mr. Charles Bachtell , Co-Founder, CEO & Director (Age 42, Pay $537.5k) Mr. Dennis M...

Who are some of Cresco Labs' key competitors?

Some companies that are related to Cresco Labs include Tilray (TLRY) , Canopy Growth (CGC) , USANA Health Sciences (USNA) , Cronos Group (CRON)...

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...

About Cresco Labs

Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.

OTC: CRLBF

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cresco Labs stock. View analyst ratings for Cresco Labs or view top-rated stocks.

Is Cresco a cannabis stock you should strongly consider? Here are two contrasting views

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bull case: Cresco is a cannabis bargain

Cresco Labs ( CRLBF -5.51% ) ranks as one of the top multi-state cannabis operators in the U.S. But its shares haven't performed well this year, falling more than 40% below the highs set in early 2021.

OTC: CRLBF

Keith Speights: Sure, Cresco's share price has fallen year to date. However, that's not a reflection on the company's underlying business strength whatsoever. Cresco's sales continue to rise with solid gross profit margins of 50% or more.

Bear case: Cresco might be biting off more than it can chew

The company operates in several of the biggest and most attractive cannabis markets in the country. Many of the states where Cresco does business present tremendous growth opportunities.

The key differentiator

Rich Duprey: I'll admit to liking the long-term potential of Cresco Labs, seeing it as a strategically positioned multistate operator (MSO) with a strong presence in some of the biggest marijuana markets. But let's temper the enthusiasm for its potential with the reality that there are a lot of moving parts right now for this pot stock.

Premium Investing Services

The main difference between the bull case and bear case for Cresco Labs comes down to the company's ability to execute, especially with acquisitions. If the company can't tie its new businesses together well, all bets are off.

Marijuana stocks were a big disappointment in 2021

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.

Acquisitions are a budding opportunity

Rich has been a Fool since 1998 and writing for the site since 2004. After 20 years of patrolling the mean streets of suburbia, he hung up his badge and gun to take up a pen full time.

Multipronged growth strategy

Cresco Labs certainly has a lot working for it in its favor. In November, it closed on its acquisition of Cure Pennsylvania, which added three dispensaries to its portfolio.

Rocket in flight?

What helps set Cresco apart from many of its rivals is its leading wholesale business. Although wholesale cannabis is lower margin than retail sales, it can make up for that with volume.

What is Cresco Labs?

Investors would do well to consider the business and not the stock price since if a company is successful, its share price will likely follow over time.

Where is Cresco Labs located?

Cresco Labs Mission and Products. It’s Cresco’s mission to “normalize, professionalize and revolutionize cannabis.”. And the company has made major strides forward due to legalization efforts across the country. Cresco Labs stock is sure to benefit from the cannabis boom that isn’t going anywhere anytime soon.

What is the ticker symbol for stock?

Cresco Labs was founded in 2013 and it’s currently headquartered in Chicago, Illinois. The business, much like other pot stocks, has taken advantage of the ever-growing list of states to legalize marijuana.

What are the risks of buying OTC stocks?

In addition, the stock trades in over-the-counter (OTC) markets in the United States under the ticker symbol CRLBF. An over-the-counter market, or off-exchange, is trading done directly between two parties without the supervision of an exchange. And nearly 50% of all stock trades were made off-exchange in 2020.

Is Cresco stock going anywhere?

However, it’s important to understand the risks of buying OTC stocks. These companies generally trade over-the-counter for a variety of reasons. For example, these reasons may include: 1 A new company that was just created 2 Companies with bad credit 3 A company with little to no profits 4 Companies that provide less accounting information than regular exchanges

Who is the CEO of Cresco Labs?

Cresco Labs stock is sure to benefit from the cannabis boom that isn’t going anywhere anytime soon. But the company also has a range of products that consumers love. From edibles to softgels, you can find many Cresco brands at dispensaries and retail locations in various states.

How many employees does Cresco have?

History. Cresco Labs was founded in 2013 by Charlie Bachtell, who currently serves as CEO, and Joe Caltabiano, who served as president until resigning on March 2, 2020. The co-founders met in 2007 while working together at Guaranteed Rate, a mortgage company based in Chicago. Despite founding Cresco in 2013, Bachtell continued working ...

When did Cresco go public?

At the start of 2018, Cresco employed roughly 100 people. By the end of the third quarter of 2018, the company had 300 employees in six states.

When did Cresco acquire Origin House?

It was the second Illinois-based cannabis company to go public on the CSE in 2018, after Green Thumb Industries. Cresco began trading on the CSE on December 3, 2018, raising $87 million; at this point, it had raised $205 million over the course of 2018. At the end of 2018, Cresco employed roughly 500 people.

What are Cresco Labs' brands?

On April 1, 2019 , Cresco announced an $850 million acquisition of Canada-based Origin House, heralded at the time as "the largest public company acquisition in the history of the U.S. cannabis industry".

Who is the CEO of Cresco?

Some of Cresco Labs' marijuana brands include Remedi, Reserve, Mindy’s Edibles, Good News, High Supply, and Wonder Wellness Co. The company has retail locations as well as many national brands available on the wholesale market. Cresco aims to focus on growth in states with a significant market in medical marijuana. Source: Cresco Labs Facebook.

How many dispensaries does Cresco have?

Cresco CEO and co-founder Charlie Bachtell said, “The Verdant acquisition significantly deepens our position in Ohio, a market that looks structurally similar to Illinois and Pennsylvania in the early years of those medical markets.

How many states does Cresco Labs operate in?

The acquisition allows Cresco to get its products into over 575 dispensaries in that state. On Feb. 16, Cresco announced that it's acquiring Verdant Creations, which has four dispensaries in Ohio. The deal will bring Cresco’s dispensary count in Ohio to five, which is the maximum permitted. The transaction continues Cresco’s pattern ...

When did Cresco acquire Origin House?

How to Buy Cresco Labs Stock and Access the Marijuana Industry. Cresco Labs is a multi-state marijuana operator in the U.S., with facilities in nine states including Illinois. The company was founded in 2013 and has 15 production facilities, 29 retail licenses, and 20 operational dispensaries.

Is Cresco Labs publicly traded?

Cresco Labs' valuation. Cresco Labs acquired Origin House in January 2020. The deal was a powerful one because it enabled Cresco to enter the largest marijuana market in the world. Origin House is one of the few companies with a distribution license in California.

Is Cresco on Robinhood?

Cresco Labs is publicly traded. Cresco Labs is a publicly-traded company. Its stock is available on the OTC (over-the-counter) market as "CRLBF.". The stock is also available on the CSE (Canadian Securities Exchange) under the ticker symbol "CL.". Cresco's stock price on CSE was $20.44 as of 9:40 a.m. on Feb. 17.

Acquisitions Are A Budding Opportunity

Multipronged Growth Strategy

Rocket in Flight?

• Investors would do well to consider the business and not the stock price since if a company is successful, its share price will likely follow over time. Analysts have set a one-year price target on Cresco Labs that sees shares surging nearly 400% to over $26 per share, suggesting that whatever misgivings the market has about the potential for marij...

See more on fool.com